Literature DB >> 26135605

Quercetin Induces Dose-Dependent Differential Morphological and Proliferative Changes in Rat Uteri in the Presence and in the Absence of Estrogen.

Huma Shahzad1, Nelli Giribabu1, Muniandy Sekaran2, Naguib Salleh1.   

Abstract

Quercetin could have profound effects on uterine morphology and proliferation, which are known to be influenced by estrogen. This study investigated the effect of quercetin on these uterine parameters in the presence and in the absence of estrogen. Ovariectomized adult female rats received peanut oil, quercetin (10, 50, and 100 mg/kg/day), estrogen, or estrogen+quercetin (10, 50, or 100 mg/kg/day) treatment for 7 consecutive days. At the end of the treatment, uteri were harvested for histological and molecular biological analyses. Distribution of proliferative cell nuclear antigen (PCNA) protein in the uterus was observed by immunohistochemistry. Levels of expression of PCNA protein and mRNA in uterine tissue homogenates were determined by Western blotting and real-time polymerase chain reaction, respectively. Our findings indicated that administration of 10 mg/kg/day of quercetin either alone or with estrogen resulted in decreased uterine expression of PCNA protein and mRNA with the percentage of PCNA-positive cells in uterine luminal and glandular epithelia markedly reduced compared with estrogen-only treatment. Changes in uterine morphology were the opposite of changes observed following estrogen treatment. Treatment with 100 mg/kg/day of quercetin either alone or with estrogen resulted in elevated PCNA protein and mRNA expression. In addition, the percentages of PCNA-positive cells in the epithelia, which line the lumen and glands, were increased with morphological features mimicking changes that occur following estrogen treatment. Following 50 mg/kg/day quercetin treatment, the changes observed were in between those changes that occur following 10 and 100 mg/kg/day quercetin treatment. In conclusion, changes in uterine morphology and proliferation following 10 mg/kg/day quercetin treatment could be attributed to quercetin's antiestrogenic properties, while changes that occur following 100 mg/kg/day quercetin treatment could be attributed to quercetin's estrogenic properties.

Entities:  

Keywords:  quercetin; uterine morphology and proliferation

Mesh:

Substances:

Year:  2015        PMID: 26135605      PMCID: PMC4685494          DOI: 10.1089/jmf.2014.3293

Source DB:  PubMed          Journal:  J Med Food        ISSN: 1096-620X            Impact factor:   2.786


  24 in total

1.  Progesterone stimulation of fluid absorption by the rat uterine gland.

Authors:  R J Naftalin; J R Thiagarajah; K C Pedley; V J Pocock; S R Milligan
Journal:  Reproduction       Date:  2002-05       Impact factor: 3.906

2.  Phytoestrogens inhibit human 17beta-hydroxysteroid dehydrogenase type 5.

Authors:  A Krazeisen; R Breitling; G Möller; J Adamski
Journal:  Mol Cell Endocrinol       Date:  2001-01-22       Impact factor: 4.102

3.  Cell proliferation in the uterus of the guinea-pig.

Authors:  S N Mehrotra; C A Finn
Journal:  J Reprod Fertil       Date:  1974-04

4.  Estrogenic and antiestrogenic activities of flavonoid phytochemicals through estrogen receptor binding-dependent and -independent mechanisms.

Authors:  B M Collins-Burow; M E Burow; B N Duong; J A McLachlan
Journal:  Nutr Cancer       Date:  2000       Impact factor: 2.900

5.  Quercetin and resveratrol potently reduce estrogen sulfotransferase activity in normal human mammary epithelial cells.

Authors:  Y Otake; A L Nolan; U K Walle; T Walle
Journal:  J Steroid Biochem Mol Biol       Date:  2000 Jul-Aug       Impact factor: 4.292

6.  Quercetin, a flavonoid phytoestrogen, ameliorates experimental allergic encephalomyelitis by blocking IL-12 signaling through JAK-STAT pathway in T lymphocyte.

Authors:  Gladson Muthian; John J Bright
Journal:  J Clin Immunol       Date:  2004-09       Impact factor: 8.317

7.  Growth-inhibitory effect of quercetin and presence of type-II estrogen-binding sites in human colon-cancer cell lines and primary colorectal tumors.

Authors:  F O Ranelletti; R Ricci; L M Larocca; N Maggiano; A Capelli; G Scambia; P Benedetti-Panici; S Mancuso; C Rumi; M Piantelli
Journal:  Int J Cancer       Date:  1992-02-01       Impact factor: 7.396

8.  Inhibition of human endometrial stromal cell proliferation by interleukin 6.

Authors:  P N Zarmakoupis; S E Rier; G B Maroulis; J L Becker
Journal:  Hum Reprod       Date:  1995-09       Impact factor: 6.918

9.  Quercetin induces type-II estrogen-binding sites in estrogen-receptor-negative (MDA-MB231) and estrogen-receptor-positive (MCF-7) human breast-cancer cell lines.

Authors:  G Scambia; F O Ranelletti; P B Panici; M Piantelli; R De Vincenzo; G Ferrandina; G Bonanno; A Capelli; S Mancuso
Journal:  Int J Cancer       Date:  1993-05-28       Impact factor: 7.396

10.  Bioflavonoid interaction with rat uterine type II binding sites and cell growth inhibition.

Authors:  B M Markaverich; R R Roberts; M A Alejandro; G A Johnson; B S Middleditch; J H Clark
Journal:  J Steroid Biochem       Date:  1988       Impact factor: 4.292

View more
  4 in total

1.  Combinatorial effects of quercetin and sex-steroids on fluid and electrolytes' (Na+, Cl-, HCO3-) secretory mechanisms in the uterus of ovariectomised female Sprague-Dawley rats.

Authors:  Huma Shahzad; Nelli Giribabu; Kamarulzaman Karim; Normadiah M Kassim; Sekaran Muniandy; Naguib Salleh
Journal:  PLoS One       Date:  2017-03-02       Impact factor: 3.240

2.  In vivo administration of quercetin ameliorates sperm oxidative stress, inflammation, preserves sperm morphology and functions in streptozotocin-nicotinamide induced adult male diabetic rats.

Authors:  Suseela Yelumalai; Nelli Giribabu; Kamarulzaman Karim; Siti Zawiah Omar; Naguib Bin Salleh
Journal:  Arch Med Sci       Date:  2018-12-30       Impact factor: 3.318

3.  Ginkgo biloba extract (EGb761) did not express estrogenic activity in an immature rat uterotrophic assay.

Authors:  Byeonghak Moon; Wonchan Kim; Cho Hee Park; Seung Min Oh
Journal:  Environ Health Toxicol       Date:  2018-09-28

4.  Dasatinib plus quercetin prevents uterine age-related dysfunction and fibrosis in mice.

Authors:  Marcelo B Cavalcante; Tatiana D Saccon; Allancer D C Nunes; James L Kirkland; Tamara Tchkonia; Augusto Schneider; Michal M Masternak
Journal:  Aging (Albany NY)       Date:  2020-01-18       Impact factor: 5.682

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.